CA2136213A1 - Tissus de taxus cultives en tant que source de taxol, taxanes connexes et autres composes antitumoraux et antiviraux - Google Patents

Tissus de taxus cultives en tant que source de taxol, taxanes connexes et autres composes antitumoraux et antiviraux

Info

Publication number
CA2136213A1
CA2136213A1 CA002136213A CA2136213A CA2136213A1 CA 2136213 A1 CA2136213 A1 CA 2136213A1 CA 002136213 A CA002136213 A CA 002136213A CA 2136213 A CA2136213 A CA 2136213A CA 2136213 A1 CA2136213 A1 CA 2136213A1
Authority
CA
Canada
Prior art keywords
taxol
taxus
roots
cell line
root
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002136213A
Other languages
English (en)
Inventor
Richard N. Arteca
Enaksha Wickremesinhe
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Penn State Research Foundation
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2136213A1 publication Critical patent/CA2136213A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D305/00—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
    • C07D305/14—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/04—Plant cells or tissues
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/02—Oxygen as only ring hetero atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Botany (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Epoxy Compounds (AREA)
CA002136213A 1992-05-21 1993-05-11 Tissus de taxus cultives en tant que source de taxol, taxanes connexes et autres composes antitumoraux et antiviraux Abandoned CA2136213A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US88661992A 1992-05-21 1992-05-21
US07/886,619 1992-05-21
PCT/US1993/004424 WO1993023555A1 (fr) 1992-05-21 1993-05-11 Tissus de taxus mis en culture utilise comme source de taxol, taxanes et autres nouveaux composes antitumoraux/antiviraux apparantes

Publications (1)

Publication Number Publication Date
CA2136213A1 true CA2136213A1 (fr) 1993-11-25

Family

ID=25389395

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002136213A Abandoned CA2136213A1 (fr) 1992-05-21 1993-05-11 Tissus de taxus cultives en tant que source de taxol, taxanes connexes et autres composes antitumoraux et antiviraux

Country Status (5)

Country Link
EP (1) EP0642586A4 (fr)
JP (1) JPH08500973A (fr)
AU (1) AU4242993A (fr)
CA (1) CA2136213A1 (fr)
WO (1) WO1993023555A1 (fr)

Families Citing this family (64)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7264951B1 (en) 1992-02-20 2007-09-04 Phyton, Inc. Enhanced production of taxol and taxanes by cell cultures of Taxus species
CA2434692A1 (fr) * 1992-04-07 1993-10-08 Paul M. Cino Induction de cellules de cal et la preparation de taxanes
WO1994020606A1 (fr) * 1993-03-05 1994-09-15 Celex Laboratories Inc. Culture de tissus vegetaux pour la production de taxol
KR950005081B1 (ko) * 1993-07-06 1995-05-18 산림청임목육종연구소 주목 종자의 씨눈 유래의 체세포배 및 체세포배성세포 혹은 그 배양배지로부터 택솔(Taxol) 및 그 유도체를 생산하는 방법
EP0706376B2 (fr) 1993-07-19 2007-08-08 Angiotech Pharmaceuticals, Inc. Compositions anti-angiogeniques et leurs procedes d'utilisation
DE69431135T2 (de) * 1993-11-15 2003-03-27 Mitsui Chemicals Inc Methode zur Herstellung von Taxan-Typ Diterpen und Methode zur Gewinnung von Kulturzellen die Taxan-Typ Diterpen in hohen Ausbeuten herstellen
CA2178541C (fr) 1995-06-07 2009-11-24 Neal E. Fearnot Dispositif medical implantable
EP1538214A1 (fr) 1996-05-24 2005-06-08 Phyton, Inc. Production améliorée de taxanes à partir de cultures cellulaires d'espèces de taxus
JP3569290B2 (ja) * 1996-09-12 2004-09-22 ビュンドー ハン タキソール類似蛋白及びその製造方法
IL121320A (en) 1997-02-23 2000-12-06 Ibr Ltd Extracts from cells or tissue of organisms which are capable of entering dormancy for inhibition of proliferation of target cells or tissue
CA2307393A1 (fr) 2000-05-01 2001-11-01 The University Of British Columbia Chimiotherapie par administration d'un ginsenoside
AU2002240755B2 (en) 2001-03-13 2007-07-05 Angiotech International Ag Micellar drug delivery vehicles and uses thereof
JP2004532847A (ja) 2001-04-20 2004-10-28 ザ ユニヴァーシティ オヴ ブリティッシュ コロンビア 疎水性薬物のためのミセル薬物送達システム
US7351542B2 (en) 2002-05-20 2008-04-01 The Regents Of The University Of California Methods of modulating tubulin deacetylase activity
AU2003300076C1 (en) 2002-12-30 2010-03-04 Angiotech International Ag Drug delivery from rapid gelling polymer composition
EP2390262A1 (fr) 2003-05-16 2011-11-30 Intermune, Inc. Ligands de récepteur de chimiokine synthétique et leurs procédés d'utilisation
US7989490B2 (en) 2004-06-02 2011-08-02 Cordis Corporation Injectable formulations of taxanes for cad treatment
US8003122B2 (en) 2004-03-31 2011-08-23 Cordis Corporation Device for local and/or regional delivery employing liquid formulations of therapeutic agents
US7846940B2 (en) 2004-03-31 2010-12-07 Cordis Corporation Solution formulations of sirolimus and its analogs for CAD treatment
US7597884B2 (en) 2004-08-09 2009-10-06 Alios Biopharma, Inc. Hyperglycosylated polypeptide variants and methods of use
WO2006089218A2 (fr) 2005-02-17 2006-08-24 The Board Of Trustees Of The Leland Stanford Junior University Procedes et compositions de modulation d'angiogenese
EP1891206B1 (fr) 2005-06-03 2013-07-24 Samyang Genexbio Corporation Production de masse de métabolites secondaires dans une culture de cellules végétales par l'utilisation d'un mélange à base de saccharides dans le milieu de culture
CN100393879C (zh) * 2005-12-26 2008-06-11 合肥宏源生物技术开发有限公司 电穿孔转Ri质粒诱发红豆杉发根的方法
CA2646156C (fr) 2006-03-22 2016-05-24 Medigene Ag Traitement du cancer du sein avec = triple recepteur negatif =
EP2043704B2 (fr) 2006-06-30 2017-04-19 Cook Medical Technologies LLC Procédés de production et de modification de revêtements en taxane destinés à des dispositifs médicaux implantables
US8409601B2 (en) 2008-03-31 2013-04-02 Cordis Corporation Rapamycin coated expandable devices
US8273404B2 (en) 2008-05-19 2012-09-25 Cordis Corporation Extraction of solvents from drug containing polymer reservoirs
WO2009143454A2 (fr) 2008-05-22 2009-11-26 Kereos, Inc. Combinaison thérapeutique anticancéreuse
WO2010005850A1 (fr) 2008-07-08 2010-01-14 The J. David Gladstone Institutes Procédés et compositions de modulation de l’angiogenèse
US8642063B2 (en) 2008-08-22 2014-02-04 Cook Medical Technologies Llc Implantable medical device coatings with biodegradable elastomer and releasable taxane agent
US20120302954A1 (en) 2011-05-25 2012-11-29 Zhao Jonathon Z Expandable devices coated with a paclitaxel composition
US20120303115A1 (en) 2011-05-25 2012-11-29 Dadino Ronald C Expandable devices coated with a rapamycin composition
US9956385B2 (en) 2012-06-28 2018-05-01 The Spectranetics Corporation Post-processing of a medical device to control morphology and mechanical properties
IN2015DN00552A (fr) 2012-07-19 2015-06-26 Redwood Bioscience Inc
EP2916835A4 (fr) 2012-11-12 2016-07-27 Redwood Bioscience Inc Composés et procédés pour produire un conjugué
PT3613439T (pt) 2013-02-15 2021-05-12 Univ California Recetor de antigénio quimérico e métodos de utilização do mesmo
US9670162B2 (en) 2013-03-14 2017-06-06 The Board Of Trustees Of The Leland Stanford Junio Mitochondrial aldehyde dehyrogenase-2 modulators and methods of use thereof
AU2014354643B2 (en) 2013-11-27 2020-03-05 Redwood Bioscience, Inc. Hydrazinyl-pyrrolo compounds and methods for producing a conjugate
CA2940269C (fr) 2014-02-19 2022-08-16 Aviv Therapeutics, Inc. Amides polycycliques se liant a l'aldehyde deshydrogenase 2 (aldh2) mitochondriale et leur utilisation dans le traitement du cancer
KR20180058759A (ko) 2015-09-25 2018-06-01 제트와이 테라퓨틱스 인코포레이티드 폴리사카라이드-비타민 접합체를 포함하는 미립자를 기재로 하는 약물 제제
US10654875B2 (en) 2015-11-12 2020-05-19 The Board Of Trustees Of The Leland Stanford Junior University Cell-penetrating, guanidinium-rich oligophosphotriesters for drug and probe delivery
TWI760319B (zh) 2015-12-30 2022-04-11 杏國新藥股份有限公司 乳癌治療
WO2017189432A1 (fr) 2016-04-26 2017-11-02 R.P. Scherer Technologies, Llc Conjugués d'anticorps et méthodes de fabrication et d'utilisation de ceux-ci
UA123020C2 (uk) 2016-06-01 2021-02-03 Сервьє Айпі Юкей Лімітед Склади поліалкіленоксид-аспарагінази та способи їхнього виготовлення й використання
TW201825087A (zh) 2017-01-05 2018-07-16 杏國新藥股份有限公司 胰臟癌治療
KR20190130559A (ko) 2017-01-18 2019-11-22 에프1 온콜로지, 인코포레이티드 Axl 또는 ror2에 대한 키메라 항원 수용체 및 이의 사용 방법
EP3388082A1 (fr) 2017-04-13 2018-10-17 Galera Labs, LLC Poly-immunothérapie anticancéreuse avec un complexe de cycle pentaaza macrocyclique
AU2019215032A1 (en) 2018-01-31 2020-09-10 Board Of Regents Of The University Of Texas System Combination cancer therapy with pentaaza macrocyclic ring complex and platinum-based anticancer agent
CN112368011A (zh) 2018-04-11 2021-02-12 俄亥俄州创新基金会 缓释微粒用于眼用药物递送的方法和组合物
JP2021530507A (ja) 2018-07-18 2021-11-11 マンザニータ ファーマシューティカルズ，インク． 神経細胞に抗がん剤を送達するためのコンジュゲート、その使用方法及び製造方法
TW202038994A (zh) 2019-01-14 2020-11-01 美商醫格耐免疫治療公司 重組痘瘡病毒及其使用方法
EP3923967A1 (fr) 2019-02-14 2021-12-22 Ignite Immunotherapy, Inc. Virus de la vaccine recombinant et ses procédés d'utilisation
MX2021012003A (es) 2019-04-02 2021-11-04 Kenjockety Biotechnology Inc Anticuerpos multiespecificos contra antigeno de cancer de la bomba de eflujo y composiciones, reactivos, kits y metodos relacionados con los mismos.
JP7266226B2 (ja) * 2019-08-22 2023-04-28 北海道三井化学株式会社 イチイ属の毛状根の製造方法
JP2021106576A (ja) 2019-12-12 2021-07-29 イグナイト・イミュノセラピー，インコーポレーテッド 変異体腫瘍溶解性ワクシニアウイルスおよびその使用法
EP4097134A1 (fr) 2020-01-29 2022-12-07 Kenjockety Biotechnology, Inc. Anticorps anti-mdr1 et leurs utilisations
WO2021247423A1 (fr) 2020-06-04 2021-12-09 Kenjockety Biotechnology, Inc. Anticorps multi-spécifiques d'un antigène associé à un cancer-pompe à efflux, ainsi que compositions, réactifs, kits et méthodes associés à ceux-ci
CN116323662A (zh) 2020-06-04 2023-06-23 肯乔克蒂生物技术股份有限公司 抗abcg2抗体及其用途
BR112023000650A2 (pt) 2020-07-14 2023-01-31 Pfizer Vírus vaccinia recombinante
CN116490522A (zh) 2020-09-02 2023-07-25 肯乔克蒂生物技术股份有限公司 抗abcc1抗体及其应用
CA3203652A1 (fr) 2020-11-13 2022-05-19 William Robert ARATHOON Anticorps anti-mrp4 (codes par le gene abcc4) et leurs utilisations
US11299700B1 (en) 2021-02-19 2022-04-12 Acequia Biotechnology, Llc Bioreactor containers and methods of growing hairy roots using the same
WO2023114658A1 (fr) 2021-12-13 2023-06-22 Kenjockety Biotechnology, Inc. Anticorps anti-abcb1
WO2023159220A1 (fr) 2022-02-18 2023-08-24 Kenjockety Biotechnology, Inc. Anticorps anti-cd47

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4942184A (en) * 1988-03-07 1990-07-17 The United States Of America As Represented By The Department Of Health And Human Services Water soluble, antineoplastic derivatives of taxol
FR2629819B1 (fr) * 1988-04-06 1990-11-16 Rhone Poulenc Sante Procede de preparation de derives de la baccatine iii et de la desacetyl-10 baccatine iii
US5019504A (en) * 1989-03-23 1991-05-28 The United States Of America As Represented By The Secretary Of Agriculture Production of taxol or taxol-like compounds in cell culture
CA2080000A1 (fr) * 1991-02-12 1992-08-13 Koji Saito Methode pour l'obtention de taxol par culture cellulaire de l'espece taxus
US5407816A (en) * 1992-02-20 1995-04-18 Phyton Catalytic, Inc. Enhanced production of taxol and taxanes by cell cultures of taxus species
WO1994020606A1 (fr) * 1993-03-05 1994-09-15 Celex Laboratories Inc. Culture de tissus vegetaux pour la production de taxol

Also Published As

Publication number Publication date
AU4242993A (en) 1993-12-13
EP0642586A4 (fr) 1995-11-29
EP0642586A1 (fr) 1995-03-15
WO1993023555A1 (fr) 1993-11-25
JPH08500973A (ja) 1996-02-06

Similar Documents

Publication Publication Date Title
CA2136213A1 (fr) Tissus de taxus cultives en tant que source de taxol, taxanes connexes et autres composes antitumoraux et antiviraux
Malik et al. Production of the anticancer drug taxol in Taxus baccata suspension cultures: a review
Fett-Neto et al. Cell culture of Taxus as a source of the antineoplastic drug taxol and related taxanes
AU672194B2 (en) Enhanced production of taxol and taxanes by cell cultures of (taxus) species
Wickremesinhe et al. Taxus callus cultures: initiation, growth optimization, characterization and taxol production
US5019504A (en) Production of taxol or taxol-like compounds in cell culture
Gibson et al. Potential of plant cell culture for taxane production
CA2194701A1 (fr) Production de taxanes dans des cultures de cellules derivees de haploides
US5527702A (en) Callus cell induction from partially submerged explant tissue in liquid medium for preparation of taxanes
US20070026506A1 (en) Method for the production of taxol and/or taxanes from cultures of hazel cells
Bruňáková et al. Selection of callus cultures of Taxus baccata L. as a potential source of paclitaxel production
Badi et al. New approach to improve taxol biosynthetic
US5871979A (en) Method for mass production of taxol by semi-continuous culture with Taxus chinensis cell culture
Majumder et al. Biotechnological approaches for the production of potential anticancer leads podophyllotoxin and paclitaxel: an overview
Sohn et al. Paclitaxel (taxol): From nutt to drug
US6248572B1 (en) Production of taxol from taxus plant cell culture adding silver nitrate
Takeya Plant tissue culture of taxoids
Wickremesinhe et al. Taxus species (yew): in vitro culture, and the production of taxol and other secondary metabolites
JP3434892B2 (ja) タキサン型ジテルペンの製造方法
JP3897267B2 (ja) タキサン型ジテルペンの製造方法
Gorzi et al. A review of the importance of Taxol production from yew (Taxus baccata L.)
Koirala et al. Biotechnological Approaches to Optimize the Production of Amaryllidaceae Alkaloids. Biomolecules 2022, 12, 893
Wickremesinhe Callus and cell suspension cultures of Taxus as a source of taxol and related taxanes
Ciddi et al. Paclitaxel (Taxol* R) from Cell and Tissue Cultures of Taxus Sp
Jaziri et al. Bioactive Taxoid Production from Natural Sources

Legal Events

Date Code Title Description
FZDE Dead